HCV Archives – Page 23 of 31 – Treatment Action Group

HIV i-Base/Treatment Action Group 2012 Pipeline Report Reveals Deep Gaps between Scientific Promise and Program Delivery

July 21, 2012
Chad Cipiti

On the eve of the XIX International AIDS Conference in Washington, D.C., a new report by HIV i-Base (U.K.) and Treatment Action Group (TAG) (U.S.) reveals the deepening gulf between new scientific advances that make it possible to prevent, treat, and in some cases cure people living with HIV, hepatitis C virus (HCV), and tuberculosis (TB), and access to these where they are most needed.

2012 Pipeline Report

July 20, 2012
Chad Cipiti

HIV, Hepatitis C Virus (HCV), and Tuberculosis (TB) Drugs, Diagnostics, Vaccines, and Preventive Technologies in Development By Polly Clayden, Simon Collins, Colleen Daniels, Nathan Geffen, Mark Harrington, Richard Jefferys, Coco Jervis, Karyn Kaplan, Erica Lessem, and Tracy Swan.

Access to Hepatitis C Treatment: A Global Movement Gains Momentum

May 10, 2012
Chad Cipiti

By Tracy Swan Being a person living with HIV/AIDS, hepatitis C, and an injection drug user, I look at my body. People want to treat my virus -- my immune system -- people want to treat my chest -- my…

Two New TAG Publications

May 9, 2012
Chad Cipiti

Research Funding Gaps Revealed Treatment Action Group has published two new reports on the crisis in national and international funding for scientific research on AIDS, tuberculosis (TB), and viral hepatitis. TB and hepatitis are diseases that affect hundreds of millions…

State AIDS Drug Assistance Program (ADAP) Hepatitis Coverage

May 9, 2012
Chad Cipiti

Hepatitis C Treatment, Psychiatric Medications (SSRIs), Growth Factors, Hepatitis Vaccines (March 2009) Hepatitis C virus (HCV) is a common and serious comorbidity among HIVpositive people in the United States; up to 30%—approximately 332,000— are living with HCV. Hepatitis C can…

A Delicate Balance: Accelerated Approval and Postmarketing Commitments

May 9, 2012
Chad Cipiti

Research presentation poster by Tracy Swan and Lei Chou; winner of a Chairman’s Choice Award at the 2008 HIV DART conference “Frontiers in Drug Development for Antiretroviral Therapies.” The complete text is available online. Populations in Preapproval Studies and…

New Hepatitis C Epidemic Outbreaks in HIV-Positive Gay Men

May 9, 2012
Chad Cipiti

Outbreaks of sexually transmitted hepatitis C infection have been reported among HIV-positive gay men. Early diagnosis and treatment can prevent serious liver disease, but too few doctors notice the warning signs. BY Tracy Swan A new epidemic of hepatitis…

Message to the New President: Join Us in the Fight Against AIDS

May 9, 2012
Chad Cipiti

Recommendations submitted by Treatment Action Group to President Barack Obama on ways to strengthen the struggle to end AIDS Demonstrate Strong Domestic and Global Leadership TAG urges President Obama to make fighting AIDS a national and global priority through…

The Hepatitis B Data Void: Making Treatment Decisions in an Evidence-Free Zone

May 4, 2012
Chad Cipiti

Making Treatment Decisions in an Evidence-Free Zone By Lei Chou New drug development; treatment strategies; natural history; long-term outcomes: The lack of support for research on hepatitis B virus is putting millions of people with the virus at risk. People…

Rapidly Progressing Hepatitis C in New York Gay Men

May 3, 2012
Chad Cipiti

New Surveillance Networks Needed By Tracy Swan Recent outbreaks of acute hepatitis C virus (HCV) among HIV-positive men who have sex with men (MSM) have been reported in England, France, Germany, Holland, and the United States. Many of these cases…